Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 738

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 738
---
 or that are subject to grants of stock options made, or that may be made, under the Legacy Plan, or that have been previously exercised.

The following table sets forth the aggregate information on all equity compensation plans as of June 30, 2024:

| Plan Category                                                                                                         
 (in thousands, except pershare amounts)                                                                               |     | Number of shares ofcommon stock to beissued upon exercise ofoutstanding stockoptions and rights(a) |     |     | Weighted-averageexercise price of stockoptions and rights$ |          |     | Number of shares ofcommon stockremaining available forfuture issuance underequity compensationplans (excludingsecurities reflected incolumn (a)) |     |
|:----------------------------------------------------------------------------------------------------------------------|:----|:---------------------------------------------------------------------------------------------------|----:|:----|:-----------------------------------------------------------|---------:|:----|:-------------------------------------------------------------------------------------------------------------------------------------------------|----:|
| Equity compensation plans approved by security holders - 2017 Plan(1)                                                 |     |                                                                                                    | 288 |     | $                                                          |    21.40 |     |                                                                                                                                                  | 144 |
| Equity compensation plans not approved by security holders - Del Mar (BC) 2013 Amended and Restated Stock Option Plan |     |                                                                                                    |   — |     | $                                                          | 2,060.08 |     |                                                                                                                                                  |   — |
| Totals                                                                                                                |     |                                                                                                    | 288 |     | $                                                          |    30.70 |     |                                                                                                                                                  | 144 |

| (1) | The Del Mar (BC) 2013 Amended and Restated Stock Option Plan refers to the Company’s previous equity compensation plan. |

| (2) | The balance of144shares of common stock available for issuance under the 2017 Plan as of June 30, 2024, is net of stock options previously exercised. |

The maximum number of shares of Company common stock with respect to which any one participant may be granted awards during any calendar year is 8% of the Company’s fully diluted shares of common stock on the date of grant (excluding the number of shares of common stock issued under the 2017 Plan and/or the Legacy Plan or subject to outstanding awards granted under the 2017 Plan and/or the Legacy Plan). No award will be granted under the 2017 Plan on, or after, July 7, 2027.

Stock options

During the year ended June 30, 2024, a total of 89